The importance of the IL-33/ST2/MyD88 axis for tumor inhibition was further confirmed in the CD8+ T cells-mediated tumor immunity through mDCs in a mouse model of Lewis lung carcinoma [178]. The gene discussed is IL33; the disease is neoplasm.